Drugplain

Desonide .5 mg/mL

desonide · LOTION · Actavis Pharma, Inc.

No Recall HistoryCurrently in Shortage
Plain English

Desonide is a lotion containing desonide at .5 mg/mL, taken topical. Manufactured by Actavis Pharma, Inc..

Key Facts

Brand Name
Desonide
Generic Name
desonide
NDC Code (Product)
0472-0803
Manufacturer
Actavis Pharma, Inc.
Strength
.5 mg/mL
Dosage Form
LOTION
Route
TOPICAL
Marketing Status
Application #
ANDA072354
Drug Class
Corticosteroid [EPC]
Marketing Start
05/28/2009

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective1,161 reports
macular degeneration780 reports
off label use409 reports
pain383 reports
nausea370 reports
headache318 reports
rash313 reports
pruritus308 reports
erythema306 reports
pyrexia300 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Desonide cream, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It should not be used for longer than two weeks unless directed by a physician.

Dosage & Administration

DOSAGE AND ADMINISTRATION Desonide cream, 0.05% should be applied to the affected area as a thin film two to four times daily depending on the severity of the condition. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within two weeks, reassessment of diagnosis may be necessary. Desonide cream, 0.05% should not be used with occlusive dressings.

Contraindications

CONTRAINDICATIONS Desonide cream, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

ADVERSE REACTIONS In controlled clinical trials, the total incidence of adverse reactions associated with the use of desonide cream, 0.05% was approximately 1%. The adverse reactions for desonide cream, 0.05% were pruritus, pain, folliculitis, rash, peripheral edema, pustular rash, sweating, erythema, irritation, and burning. Laboratory abnormalities were found in 3% of the patients. These were hyperglycemia (2%) and liver function abnormality (1%). The following additional local adverse reactions have been reported infrequently with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings and higher potency corticosteroids. These reactions are listed in approximate decreasing order of occurrence: dryness, folliculitis, acneiform eruptions, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, miliaria, burning and hypopigmentation.

Frequently Asked Questions

What is Desonide used for?

Desonide contains desonide. It is a lotion taken topical. Consult your doctor for specific uses.

Is Desonide a controlled substance?

Desonide is not classified as a controlled substance by the DEA.

What is the generic name for Desonide?

The generic name for Desonide is desonide. There are 1 other brand versions of desonide.

What is the NDC code for Desonide .5 mg/mL?

The NDC (National Drug Code) for Desonide .5 mg/mL is 0472-0803, listed by Actavis Pharma, Inc..

Product NDC

0472-0803

Package NDC

0472-0803-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)